These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9458669)

  • 1. Professional ideologies and the development of syringe exchange: Wales as a case study.
    Keene JM; Stimson GV
    Med Anthropol; 1997 Dec; 18(1):85-105. PubMed ID: 9458669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
    Birkhead GS; Klein SJ; Candelas AR; O'Connell DA; Rothman JR; Feldman IS; Tsui DS; Cotroneo RA; Flanigan CA
    Int J Drug Policy; 2007 Oct; 18(5):417-25. PubMed ID: 17854731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary syringe exchange as a model for HIV prevention programs in the Russian Federation.
    Irwin K; Karchevsky E; Heimer R; Badrieva L
    Subst Use Misuse; 2006; 41(6-7):979-99. PubMed ID: 16809182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of policy in community pharmacies' response to injection-drug use: results of a nationwide Canadian survey.
    Myers T; Cockerill R; Millson M; Rankin J; Worthington C
    AIDS Public Policy J; 1996; 11(2):78-88. PubMed ID: 10915241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Community pharmacist perspectives on HIV/AIDS and interventions for injection drug users in Canada.
    Myers T; Cockerill R; Worthington C; Millson M; Rankin J
    AIDS Care; 1998 Dec; 10(6):689-700. PubMed ID: 9924524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV prevention and drug treatment services for drug misusers: a national study of community pharmacists' attitudes and their involvement in service specific training.
    Sheridan J; Strang J; Taylor C; Barber N
    Addiction; 1997 Dec; 92(12):1737-48. PubMed ID: 9581006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Needle syringe acquisition and HIV prevention among injecting drug users: a treatise on the "good" and "not so good" public health practices in South Asia.
    Panda S; Sharma M
    Subst Use Misuse; 2006; 41(6-7):953-77. PubMed ID: 16809181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Syringe exchange in community pharmacies--The Portuguese experience.
    Torre C; Lucas R; Barros H
    Int J Drug Policy; 2010 Nov; 21(6):514-7. PubMed ID: 20956074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of a pilot study on needle and syringe exchange program among injecting drug users in a community in Guangdong, China].
    Lin P; Fan ZF; Yang F; Wu ZY; Wang Y; Liu YY; Ming ZQ; Li WJ; Luo W; Fu XB; Mai XR; Xu RH; Feng WY; He Q
    Zhonghua Yu Fang Yi Xue Za Zhi; 2004 Sep; 38(5):305-8. PubMed ID: 15498241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Service Providers of Needle Syringe Program in Preventing HIV/AIDS.
    Tsai TI; Morisky DE; Chen YM
    AIDS Educ Prev; 2010 Dec; 22(6):546-57. PubMed ID: 21204630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Access to syringes in three Russian cities: implications for syringe distribution and coverage.
    Sarang A; Rhodes T; Platt L
    Int J Drug Policy; 2008 Apr; 19 Suppl 1():S25-36. PubMed ID: 18313910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 'Social evils' and harm reduction: the evolving policy environment for human immunodeficiency virus prevention among injection drug users in China and Vietnam.
    Hammett TM; Wu Z; Duc TT; Stephens D; Sullivan S; Liu W; Chen Y; Ngu D; Des Jarlais DC
    Addiction; 2008 Jan; 103(1):137-45. PubMed ID: 18028519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Community pharmacy harm reduction services for drug misusers: national service delivery and professional attitude development over a decade in Scotland.
    Matheson C; Bond CM; Tinelli M
    J Public Health (Oxf); 2007 Dec; 29(4):350-7. PubMed ID: 17986490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Needle and syringe exchange programs in Amsterdam.
    Witteveen E; Schippers G
    Subst Use Misuse; 2006; 41(6-7):835-6. PubMed ID: 16809172
    [No Abstract]   [Full Text] [Related]  

  • 15. Human immunodeficiency virus and hepatitis C virus testing services at syringe exchange programs: availability and outcomes.
    Heinzerling KG; Kral AH; Flynn NM; Anderson RL; Scott A; Gilbert ML; Asch SM; Bluthenthal RN
    J Subst Abuse Treat; 2007 Jun; 32(4):423-9. PubMed ID: 17481466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Staff perceptions of syringe dispensing machines in Australia: a pilot study.
    Islam MM; Conigrave KM; Stern T
    Subst Use Misuse; 2009; 44(4):490-501. PubMed ID: 19283622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Residual injection risk behavior, HIV infection, and the evaluation of syringe exchange programs.
    Des Jarlais DC; Braine N; Yi H; Turner C
    AIDS Educ Prev; 2007 Apr; 19(2):111-23. PubMed ID: 17411414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engaging primary health care workers in drug and alcohol and mental health interventions: challenges for service delivery in rural and remote Australia.
    Allan J
    Aust J Prim Health; 2010; 16(4):311-8. PubMed ID: 21138699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Syringe exchange in Canada: good but not enough to stem the HIV tide.
    Hankins CA
    Subst Use Misuse; 1998 Apr; 33(5):1129-46. PubMed ID: 9596380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measuring effectiveness of needle and syringe exchange programs for prevention of HIV among injecting drug users: Response to Amundsen.
    Maher L; Iversen J; Kaldor J
    Addiction; 2006 Dec; 101(12):1834-6. PubMed ID: 17156184
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.